Triple-negative versus non-triple-negative invasive breast carcinoma: a comparison of clinical-pathological characteristics, therapeutic profiles, and outcomes in a hospital cohort
Introduction: Triple-negative breast carcinoma (TNBC), defined by the absence of estrogen receptor, progesterone receptor, and HER2 expression, is the molecular subtype with the worst prognosis, with therapeutic options limited to chemotherapy and immunotherapy. Objective: To compare clinical-pathological characteristi...